Systemic candidiasis in critical patients: Risk predictors
DOI:
https://doi.org/10.24265/horizmed.2018.v18n1.11Keywords:
Candida albicans, Infection, Invasive candidiasis, CandidemiaAbstract
Candida sp. is the microorganism most frequently involved in fungal infections in critically ill patients. Candidemia is the most common form of invasive candidiasis entering the bloodstream from the gastrointestinal tract and skin. Worldwide candidemia stands out as one of the leading causes of morbidity with significant increases in its incidence and prevalence in recent years. In addition, it raises the costs of hospital care. Although several studies show that early initiation of antifungal treatment improves patients’ prognosis, there are difficulties with existing diagnostic tests, because they do not have an adequate level of sensitivity and optimum performance. For this reason, various clinical indices are currently being used as predictors of invasive candidiasis, such as Ostrosky Candida Score, Candida Score, Pittet Candida Colonization Index, among others, which have a high negative predictive value that allows to recognize patients who do not benefit from an early initiation of an antifungal treatment while the diagnosis is confirmed by laboratory. Antifungal therapy available for the treatment of candidemia in the ICU consists basically of three groups of drugs: azoles, polyenes and echinocandins. Despite the validation of predictors of invasive candidiasis in other countries, it is still unknown which of these would be the most effective for predicting this disease in the region.
Downloads
References
Garnacho-Montero J, Díaz-Martín A, De Piappón MR-P, García-Cabrera E. Infección fúngica invasiva en los pacientes ingresados en las áreas de críticos. Enferm Infecc Microbiol Clin. 2012;30(6):338-43. Disponible en: https://www.sciencedirect.com/science/article/pii/S0213005X12001206
Dimopoulos G, Antonopoulou A, Armaganidis A, Vincent J-L. How to select an antifungal agent in critically ill patients. J Crit Care. 2013;28(5):717-27. Disponible en: https://www.sciencedirect.com/science/article/pii/S0883944113001159
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39 (3):309-17. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15306996
Kim S, Yoon Y, Kim M, Sohn J. Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia. J Antimicrob Chemother. 2013; 68 (12):2890-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23825380
Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E, Pintado V, Cobo J, Fresco G, et al. Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect. 2012; 65 (1):64-70. Disponible en: https://www.sciencedirect.com/science/article/pii/S0163445312000412
Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014; 10:95-105. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928396/
Cisterna R, Ezpeleta G, Telleria O, Spanish Candidemia Surveillance Group. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol. 2010; 48 (11):4200-6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020865/
Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014; 31 (1):42-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S1130140613001010
Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014; 43 (1):78-81. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24182454
Cortés JA. Epidemiology of the Candida spp. in Colombia and susceptibility in woman. Infect. 2009;13(1):3-5.
Giri S, Kindo A. A review of Candida species causing blood stream infection. Indian J Med Microbiol. 2012;30 (3): 270-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22885191
Almeida A, Mesquita C, Svidzinski T, Oliveira K. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2013;46 (3):335-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23856873
Ajenjo H, Aquevedo S, Guzmán D, Poggi M, Calvo A, Castillo V, et al. Epidemiologial profile of invasive candidiasis in intensive care units at a university hospital. Rev Chilena Infectol. 2011;28 (2):118-22. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21720690
Chi H, Yang Y, Shang S, Chen K, Yeh K, Chang F, et al. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J Microbiol Immunol Infect. 2011; 44 (5):369-75. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21524971
De Luca C, Guglielminetti M, Ferrario A, Calabr M, Casari E. Candidemia: species involved, virulence factors and antimycotic susceptibility. New Microbiol. 2012; 35 (4):459-68. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23109013
Yapar N, Pullukcu H, Avkan-Oguz V, Sayin-Kutlu S, Ertugrul B, Sacar S, et al. Evaluation of species distribution and risk factors of candidemia: A multicenter case-control study. Med Mycol. 2011; 49 (1):26-31. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20662635
Cervera C. Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento. Enferm Infecc Microbiol Clin. 2012; 30 (8):483–491. Disponible en: https://www.sciencedirect.com/science/article/pii/S0213005X12001073
Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, et al. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Scand J Infect Di. 2008;40(5):414-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/18418802
Messer S, Jones R, Fritsche T. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol. 2006;44 (5):1782-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479200/
Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care. 2011;15(4):R198. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387640/
Corzo-Leon DE, Alvarado-Matute T, Colombo AL, Cornejo- Juarez P, Cortes J, Echevarria JI, et al. Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals. PloS one. 2014;9(5):e97325. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097325
Cortés J, Jaimes J, Leal A. Incidence and prevalence of candidemia in critically ill patients in Colombia. Rev Chilena Infectol. 2013;30 (6):599-604. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24522301
Shorr AF, Tabak YP, Johannes RS, Sun X, Spalding J, Kollef MH. Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care. 2009;13(5):R156. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19788756/
Gambero G, Gonçalves M, Martins M, Basile A, Martinez R. Evaluation of the predictive indices for candidemia in an adult intensive care unit. Rev Soc Bras Med Trop. 2015, 48(1):77-82. Disponible en: http://www.scielo.br/scielo.php?pid=S0037-86822015000100077&script=sci_abstract
Pfaller M, Diekema D. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20 (1):133-63. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797637/
Poikonen E, Lyytikäinen O, Anttila V, Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis. 2003; 9 (8):985-90. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020607/
Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004; 38 (3):311-20. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/14727199
Bassetti M, Merelli M, Righi E, Díaz-Martín A, Rosello EM, Luzzati R, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol. 2013;51 (12):4167-72. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838046/
Menzin J, Meyers J, Friedman M, Perfect J, Langston A, Danna R, et al. Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm. 2009;66(19):1711-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19767376
Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother. 2012; 67 (5):1181-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22351683
Tortorano A, Prigitano A, Lazzarini C, Passera M, Deiana M, Cavinato S, et al. A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection. 2013;41 (3):655-62. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23559357
Goel N, Ranjan P, Aggarwal R, Chaudhary U, Sanjeev N. Emergence of nonalbicans Candida in neonatal septicemia and antifungal susceptibility: experience from a tertiary care center. J Lab Physicians. 2009; 1 (2):53-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167968/
Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection. 2007; 35 (4):256-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17646917
Chen S, Slavin M, Nguyen Q, Marriott D, Playford EG, Ellis D, et al. Active surveillance for candidemia, Australia. Emerg Infect Dis. 2006; 12 (10):1508-16. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290948/
Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One. 2013; 8 (3):e59373. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23527176
Cortés JA, Prada G. Protocolo de estudio y manejo de pacientes con candidiasis sistémica en adultos. Infect. 2012; 16 (3): 118-122. Disponible en: http://www.elsevier.es/es-revista-infectio-351-articulo-protocolo-estudio-manejo-pacientes-con-S0123939212700371
Craver CW, Tarallo M, Roberts CS, Blanchette CM, Ernst FR. Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis. Clin Ther. 2010;32(14):2467-77. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21353115
Ostrosky-Zeichner L, Sable C, Sobel J, Alexander B, Donowitz G, Kan V, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J. Clin Microbiol infect Dis. 2007; 26(4): 271-276. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17333081
Cortés J, Concha M, Cediel T, Castillo J. Métodos diagnósticos en candidemia: una revisión sistemática de la literatura con meta-análisis. Rev Chil Infectol. 2011;28 (5):423-8. Disponible en: https://scielo.conicyt.cl/scielo.php?pid=S0716-10182011000600006&script=sci_arttext
Mondelli A, Niéro L, Bagagli E, Camargo C, Bruder A, Sugizaki MF, et al. Candidemia in a Brazilian tertiary hospital: microbiological and clinical features over a six-year period. The Journal of Venomous Animals and Toxins including Tropical Diseases. 2012;18 (2): 244-252. Disponible en: http://www.scielo.br/scielo.php?pid=S1678-91992012000200015&script=sci_arttext&tlng=es
Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive Fungal Infections in the ICU: How to Approach, How to Treat. Molecules. 2014; 19(1): 1085-1119. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24445340
Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51(3):230-47. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/16230221
Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts J. Can yeast isolation in peritoneal fluid be predicted in intensivecare unit patients with peritonitis?. Crit Care Med. 2003;31 (3): 752-757. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/12626979
Astrid M, Lashof O, Rothova A, Sobel J, Ruhnke M, Pappas P, et al. Ocular Manifestations of Candidemia. Clin Infect Dis. 2011; 53 (3):262–268. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21765074
Tambyah P, Maki D. Catheter-associated urinary tract intection is rarely symptomatic, A prospective study of 1497 Catheterized patients. Arc Intern Med. 2000;160(5): 678-682. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10724054
Kauffman C, Vazquez J, Sobel J, Gallis H, McKinsey D, Karchmer A, et al. Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients. Clin Infect Dis. 2000; 30(1):14–8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10619726
Lopes Colombo A, Cortes JA, Zurita J, Guzman-Blanco M, Alvarado Matute T, Queiroz Telles Fd, et al. Recomendaciones para el diagnóstico de la candidemia en América Latina. Rev Iberoam Micol. 2013;30(1):150-7. Disponible en: http://www.elsevier.es/es-revista-revista-iberoamericana-micologia-290-articulo-recomendaciones-el-diagnostico-candidemia-america-S1130140613000545
Fernandez J, Erstad B, Petty W, David E. Time to positive culture and identification for Candida blood stream infections. Diagn Microbiol Infect Dis. 2009;64(4): 402–407. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19446982
Kauffman C, Peter G, Jack D, Sobel, William E. Essentials of Clinical Mycology. 2ª ed. New York, United States: Springer; 2011
Kiehn TE, Wong B, Edwards FF, Armstrong D. Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol. 1983;18(2):300-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270795/
Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol. 2005;43(1):65-84. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15765060
Pemán J, Zaragoza R. Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico. Rev Iberoam Micol. 2012;29 (2):71-75. Disponible en: http://www.elsevier.es/es-revista-revista-iberoamericana-micologia-290-articulo-hacia-el-diagnostico-temprano-candidiasis-S1130140612000381
Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, et al. Prospective survey of (1→ 3)-β-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol. 2011;49(1):58-61. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21048005
Ahmed A, Azim A, Baronia AK, Marak KRS, Gurjar M. Risk prediction for invasive candidiasis. ndian J Crit Care Med. 2014;18(10):682-688. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195199/
Bruyère R, Quenot J-P, Prin S, Dalle F, Vigneron C, Aho S, et al. Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU. BMC Infect Dis. 2014;14(1):385. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25015848
Serefhanoglu K, Timurkaynak F, Can F, Cagir U, Arslan H, Ozdemir FN. Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis. J Formos Med Assoc. 2012;111(6):325-32. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22748623
Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695-703. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19441981
Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. CHEST Journal. 2003;124(6):2244-55. Disponible en: https://www.sciencedirect.com/science/article/pii/S0012369215316858
González MF, León C, Ruiz-Santana S, Saavedra P, Group CIS.Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit care. 2012;16(3):R105. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22698004
Neoh C, Slavin M, Chen S, Stewart K, Kong D. Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives. Int J Antimicrob Agents. 2014; 43 (3):207-14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24670423
Cortés J, Russi J. Equinocandinas. Rev Chil Infect. 2011; 28 (6):529-36. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182011000700004
Skrobik Y, Laverdiere M. Why Candida sepsis should matter to ICU physicians. Crit Care Clin. 2013;29(4):853-64. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24094381
Pappas P, Kauffman C, Andes D, Benjamin D, Calandra T, Edwards J, et al. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48 (5):503-35. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19191635
Chahoud J, Kanafani ZA, Kanj SS. Management of candidaemia and invasive candidiasis in critically ill patients. International journal of antimicrobial agents. 2013;42:S29-S35. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23664579
Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, Hadley S, León C, Nucci M, et al. Early treatment of candidemia in adults: a review. Med Mycol. 2011; 49 (2):113-20. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20818922
Gedik H, Şimşek F, Yıldırmak T, Kantürk A, Arıca D, Aydın D, et al. Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage. Therapeutics and clinical risk management. 2014;10:305-312. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011927/
Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1(1):37. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21906271
Eschenauer G, Carver P, Lin S, Klinker K, Chen Y, Potoski B, et al. Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study. J Antimicrob Chemother. 2013; 68 (4):922-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23212115
Gómez J, García E, Espinosa C, Ruiz J, Canteras M, Hernández A, et al. Nosocomial candidemia at a general hospital: prognostic factors and impact of early empiric treatment on outcome (2002–2005). Med Clin (Barc). 2010;134(1):1–5. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19913258
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
